Dafna Capital Management LLC Procept Bio Robotics Corp Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$45.73 - $69.19 $1.87 Million - $2.84 Million
-41,001 Reduced 74.55%
13,994 $854,000
Q1 2024

May 15, 2024
SELL
$40.38 - $50.75 $335,355 - $421,478
-8,305 Reduced 13.12%
54,995 $2.72 Million
Q4 2023

Feb 14, 2024
SELL
$24.89 - $43.41 $99,560 - $173,640
-4,000 Reduced 5.94%
63,300 $2.65 Million
Q3 2023

Nov 14, 2023
BUY
$30.02 - $38.81 $1.78 Million - $2.3 Million
59,300 Added 741.25%
67,300 $2.21 Million
Q2 2023

Aug 14, 2023
BUY
$26.7 - $37.02 $213,600 - $296,160
8,000 New
8,000 $282,000

Others Institutions Holding PRCT

# of Institutions
267
Shares Held
38M
Call Options Held
262K
Put Options Held
257K
View Full List

About PROCEPT BioRobotics Corp

PRCT Quotes by TradingView
  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.34B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email